Liver transplantation for hepatocellular carcinoma: The hepatitis C quandary
Francis Y. Yao – 30 May 2007
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end‐stage liver disease system
Fabio Piscaglia, Valeria Camaggi, Matteo Ravaioli, Gian Luca Grazi, Matteo Zanello, Simona Leoni, Giorgio Ballardini, Giulia Cavrini, Antonio Daniele Pinna, Luigi Bolondi – 30 May 2007 – The best prioritization of patients with hepatocellular carcinoma (HCC) waiting for liver transplantation under the model for end‐stage liver disease (MELD) allocation system is still being debated. We analyzed the impact of a MELD adjustment for HCC, which consisted of the addition of an extra score (based on the HCC stage and waiting time) to the native MELD score.
Engulfment of apoptotic cells expressing HCV proteins leads to differential chemokine expression and STAT signaling in human dendritic cells
Anne M. Wertheimer, Stephen J. Polyak, Rachel Leistikow, Hugo R. Rosen – 30 May 2007 – In the majority of cases, infection with hepatitis C virus (HCV) becomes chronic and is often associated with impaired innate and adaptive immune responses. The mechanisms underlying viral persistence and lack of protective immunity are poorly understood. Considering that dendritic cells (DCs) play critical roles in initiating and modulating immune responses, we explored the effect of HCV proteins on DC gene and protein expression, phenotype, and function.
Immunoglobulin G4 associated cholangitis: Description of an emerging clinical entity based on review of the literature
Einar Björnsson, Suresh T. Chari, Thomas C. Smyrk, Keith Lindor – 30 May 2007
HIV and liver disease forum: Conference proceedings
Kenneth E. Sherman, Marion Peters, Margaret James Koziel – 30 May 2007
Advocacy: What is a nice scientist like you doing in Washington, DC?
Norman D. Grace, Lyle B. Dennis – 30 May 2007
Restoration of p53 function: A new therapeutic strategy to induce tumor regression?
Naiara Beraza, Christian Trautwein – 30 May 2007
Towards a better liver transplant allocation system
A.K. Burroughs, L. Marelli, E. Cholongitas, P. Manousou, K. Rolles, V. Karam, V. Delvart, R. Adam, C. Sabin – 30 May 2007
Tonsil enlargement after liver transplantation in adults—reason enough for tonsillectomy? Two cases of tonsillar posttransplantation lymphoproliferative disease
Krzysztof Mucha, Bartosz Foroncewicz, Kazimierz Niemczyk, Bogna Ziarkiewicz‐Wróblewska, Olimpia Stanisławek‐Sut, Krzysztof Zieniewicz, Marek Krawczyk, Leszek Pączek – 30 May 2007 – Posttransplantation lymphoproliferative disease (PTLD) is a well‐known complication of solid organ and bone marrow transplantation. It is agreed that the main causes of PTLD are chronic infection with Epstein‐Barr virus (EBV); the intensity, rather then the type, of immunosuppression used; and underlying recipient disease.
Ethanol and fish oil induce NFκB transactivation of the collagen α2(I) promoter through lipid peroxidation–driven activation of the PKC‐PI3K‐Akt pathway
Natalia Nieto – 30 May 2007 – To analyze whether fish oil, as a source of polyunsaturated fatty acids from the n‐3 series, could synergize with ethanol to promote collagen I upregulation in vivo, collagen α2(I) promoter‐βGal (COL1A2‐βGal) transgenic mice were fed a diet enriched in fish oil in the presence of ethanol (ethanol group) or dextrose (control group).